15 May 2020 | Views
Dr. B. Partha Saradhi Reddy, Chairman, Hetero Group of Companies, Hyderabad talks about how his company is contributing in fighting the pandemic
"Hetero is pleased to partner with Gilead to enable access for Remdesivir to India and other developing countries at this crucial time. This agreement also illustrates the significance of global collaboration and the need for coming together to fight the health crises impacting humanity. Hetero has developed this product in India and has already been working with the government, ICMR, and DCGI for necessary studies and approvals to bring this product to treat COVID-19 patients in India."
Dr. B. Partha Saradhi Reddy, Chairman, Hetero Group of Companies, Hyderabad